Effect of capsaicin on nasal secretion in anesthetized ferrets.
In urethan-anesthetized ferrets, we investigated the nasal response to capsaicin infused via a catheter inserted retrogradely into the lingual artery. Capsaicin dose-dependently increased fluid output from the nose (nasal fluid output) and the lateral nasal gland (glandular fluid output). The secretory response to capsaicin (80 nmol/kg ia) was completely blocked by atropine and hexamethonium, indicating that a cholinergic reflex mediates capsaicin-induced nasal hypersecretion in this model. The amount of nasal secretions collected as nasal fluid output was similar to that collected as glandular fluid output, indicating that the lateral nasal gland contributes significantly to this increase in nasal secretions induced by intra-arterially administered capsaicin. In addition, the nasal fluid output had a higher protein concentration and osmolality than the glandular fluid output. This finding suggests that the gland is not the sole site of action of capsaicin on the nasal secretory response. It is likely that capsaicin also increases microvascular permeability, thereby contributing further to the alteration in the nasal secretions. Finally, repeated subcutaneous injections of capsaicin significantly reduced the secretory response to capsaicin, indicating the development of desensitization in vivo. These results support the role of capsaicin-sensitive sensory nerves in mediating a secretory response in the ferret nose.
Mizoguchi
H
H
Procter & Gamble Company, Miami Valley Laboratories, Cincinnati, Ohio 45239-8707.
Bergeron
M L
ML
D000344:Afferent Pathways / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001826:Body Fluids / Q000378:metabolism; D002211:Capsaicin / Q000008:administration & dosage / Q000494:pharmacology*; D004351:Drug Resistance; D005289:Ferrets; D018738:Hexamethonium; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007261:Infusions, Intra-Arterial; D008297:Male; D009297:Nasal Mucosa / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism; D009412:Nerve Fibers / Q000187:drug effects / Q000502:physiology
D006584:Hexamethonium Compounds; D018738:Hexamethonium; D001285:Atropine; D002211:Capsaicin